Chemoinformaics analysis of 2-(2-Hydroxypropyl)-6-methylpiperidine
Molecular Weight | 157.257 | nRot | 2 |
Heavy Atom Molecular Weight | 138.105 | nRig | 6 |
Exact Molecular Weight | 157.147 | nRing | 1 |
Solubility: LogS | -0.432 | nHRing | 1 |
Solubility: LogP | 0.867 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 19 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 9 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 29.6011 |
nHD | 2 | BPOL | 19.6309 |
QED | 0.633 |
Synth | 3.778 |
Natural Product Likeliness | 1.576 |
NR-PPAR-gamma | 0.007 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.768 |
HIA | 0.037 |
CACO-2 | -4.669 |
MDCK | 0.0000382 |
BBB | 0.147 |
PPB | 0.101396 |
VDSS | 2.046 |
FU | 0.875623 |
CYP1A2-inh | 0.058 |
CYP1A2-sub | 0.859 |
CYP2c19-inh | 0.094 |
CYP2c19-sub | 0.729 |
CYP2c9-inh | 0.006 |
CYP2c9-sub | 0.22 |
CYP2d6-inh | 0.143 |
CYP2d6-sub | 0.885 |
CYP3a4-inh | 0.004 |
CYP3a4-sub | 0.37 |
CL | 8.837 |
T12 | 0.321 |
hERG | 0.046 |
Ames | 0.054 |
ROA | 0.189 |
SkinSen | 0.615 |
Carcinogencity | 0.296 |
EI | 0.054 |
Respiratory | 0.94 |
NR-Aromatase | 0.002 |
Antiviral | No |
Prediction | 0.932817 |